DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02734810 (ClinicalTrials.gov)	June 2016	6/4/2016	SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis	A Phase 3, Open-Label Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency	Exocrine Pancreatic Insufficiency;Cystic Fibrosis	Drug: Liprotamase Powder for Oral Solution	Anthera Pharmaceuticals	NULL	Completed	N/A	N/A	All	15	Phase 3	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02734810
(ClinicalTrials.gov)

June 2016

6/4/2016

SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis

A Phase 3, Open-Label Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency

Exocrine Pancreatic Insufficiency;Cystic Fibrosis

Drug: Liprotamase Powder for Oral Solution

Anthera Pharmaceuticals

NULL

Completed

N/A

All

Phase 3

United States